Lublin FD - Search Results

1

How patients with multiple sclerosis acquire disability.

Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA. Lublin FD, et al. Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016. Brain. 2022. PMID: 35104840 Free PMC article.

2

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference.

Lublin FD, Whitaker JN, Eidelman BH, Miller AE, Arnason BG, Burks JS. Lublin FD, et al. Neurology. 1996 Jan;46(1):12-8. doi: 10.1212/wnl.46.1.12. Neurology. 1996. PMID: 8559358 Review.

3

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Miller DH, et al. Among authors: lublin fd. Ann Neurol. 1996 Jan;39(1):6-16. doi: 10.1002/ana.410390104. Ann Neurol. 1996. PMID: 8572668

4

Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Lublin FD, Reingold SC. Lublin FD, et al. Neurology. 1996 Apr;46(4):907-11. doi: 10.1212/wnl.46.4.907. Neurology. 1996. PMID: 8780061

5

Clinical outcomes assessment in multiple sclerosis.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1996 Sep;40(3):469-79. doi: 10.1002/ana.410400321. Ann Neurol. 1996. PMID: 8797541 Review.

6

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.

Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La Rocca N, Lopez S. Miller AE, et al. Among authors: lublin fd. Neurology. 1997 Feb;48(2):312-4. doi: 10.1212/wnl.48.2.312. Neurology. 1997. PMID: 9040712 Clinical Trial.

7

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1997 Sep;42(3):379-82. doi: 10.1002/ana.410420318. Ann Neurol. 1997. PMID: 9307263

8

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Cutter GR, et al. Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871. Brain. 1999. PMID: 10355672

9

Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS.

Rice GP, Ebers GC, Lublin FD, Knobler RL. Rice GP, et al. Among authors: lublin fd. Neurology. 1999 Jun 10;52(9):1893-5. doi: 10.1212/wnl.52.9.1893. Neurology. 1999. PMID: 10371541 Clinical Trial.

10

Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. North American Linomide Investigators.

Noseworthy JH, Wolinsky JS, Lublin FD, Whitaker JN, Linde A, Gjorstrup P, Sullivan HC. Noseworthy JH, et al. Among authors: lublin fd. Neurology. 2000 May 9;54(9):1726-33. doi: 10.1212/wnl.54.9.1726. Neurology. 2000. PMID: 10802775 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page